Guanosine Diphosphate
Daten werden ergänzt – meist innerhalb einer Minute fertig
Grundinformationen
- CAS
146-91-8- Standard-SMILES
Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1- InChIKey
QGWNDRXFNXRZMB-UUOKFMHZSA-N- Summenformel
- C10H15N5O11P2
- Durchschnittliche Molmasse
- 443,2 g/mol
- Monoisotopische Masse
- 443,02432956
Überblick
GDP is a purine ribonucleoside 5'-diphosphate resulting from the formal condensation of the hydroxy group at the 5' position of guanosine with pyrophosphoric acid. It has a role as an uncoupling protein inhibitor, a mouse metabolite and an Escherichia coli metabolite. It is a purine ribonucleoside 5'-diphosphate and a guanosine 5'-phosphate. It is a conjugate acid of a GDP(2-).
Namen und Bezeichner
- Bevorzugter Name
- Guanosine Diphosphate
- IUPAC
- [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate
Namen und Synonyme
Guanosine 5'-diphosphate146-91-8GUANOSINE DIPHOSPHATEguanosine-5'-diphosphateGuanosine 5'-(trihydrogen diphosphate)Guanosine pyrophosphateCHEBI:17552DTXSID90163254HLJ737P865[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid[(2R,3S,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate
Weitere Namen anzeigen
Diphosphate, GuanosineGuanosine 5' Diphosphate5'-Diphosphate, Guanosine(((((2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)(hydroxy)phosphoryl)oxy)phosphonic acid((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl phosphono hydrogen phosphate((2R,3S,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl phosphono hydrogen phosphateGuanosine 5' Trihydrogen DiphosphateGuanosine 5'-Trihydrogen Diphosphate
Datenbank-Bezeichner
Eigenschaften
Berechnete StruktureigenschaftenWird ergänzt
- XLogP
- -4,6
- Polarare Oberfläche (TPSA)
- 248 Ų
- H-Brücken-Donoren
- 7
- H-Brücken-Akzeptoren
- 13
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 28
- Formalladung
- 0
- Komplexität
- 760
Experimentelle und physikochemische Eigenschaften
DrugsPharmaceuticals -> Listed in ZINC15
Physical DescriptionSolid
Collision Cross Section
191.5 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
192 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
Chemie und Industrie
Pharmakologische Informationen
Cellular LocationsCytoplasm
Metabolite Pathways2-ketoglutarate dehydrogenase complex deficiency
Zugehörige Reaktionen
6
Notizen zur Verbindung
Wird geladen…